International Stem Cell Corporation Announces Strong Financial Results for the Three and Nine-Months ended September 30, 2018
November 15, 2018 08:30 ET
|
International Stem Cell Corporation
Increases in Revenues and Profit MarginsNet Income Realized for the Quarter CARLSBAD, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO)...
International Stem Cell Corporation Announces Positive Top-Line Preliminary Results from Parkinson’s Disease Clinical Trial
November 05, 2018 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Nov. 05, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation to Present Clinical Data at the Society for Neuroscience Annual Meeting
October 30, 2018 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation Doses Tenth Patient in Parkinson's Disease Clinical Trial
October 08, 2018 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation Announces Record Sales and Operating Results for the Three and Six-Months ended June 30, 2018
August 15, 2018 07:00 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Aug. 15, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation Developed 3D Liver Structures
August 06, 2018 07:00 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation Announces Operating Results for the Quarter Ended March 31, 2018
May 22, 2018 07:00 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., May 22, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation is Valued at $34 Million Market Value by Edison Investment Research
May 14, 2018 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing...
International Stem Cell Corporation Granted Key Patent in US
May 07, 2018 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based biotechnology...